Comprometimento cognitivo e qualidade de vida de pacientes submetidos ao transplante de células-tronco hematopoiéticas
DOI:
https://doi.org/10.5294/aqui.2021.21.2.6Palavras-chave:
Qualidade de vida, disfunção cognitiva, transplante de células-tronco hematopoéticas, neoplasias, transplante de medula ósseaResumo
Objetivo: avaliar e correlacionar a qualidade de vida geral e a função cognitiva de pacientes adultos com câncer hematológico submetidos ao transplante de células-tronco hematopoéticas autólogo e alogênico até três anos após o tratamento.
Materiais e método: estudo longitudinal, observacional e analítico com 55 pacientes, num hospital de referência na América Latina, de setembro de 2013 a fevereiro de 2019, com o instrumento Quality of Life Questionnarie-Core 30, analisado com os testes coeficiente de correlação de Spearman e o Generalized Linear Mixed Model.
Resultados: a qualidade de vida geral no transplante autólogo e alogênico apresentaram declínio na fase de pancitopenia (59,3 e 55,3, respectivamente). Houve comprometimento da função cognitiva no grupo autólogo no pós-transplante dois anos (61,90) e no grupo alogênico (74), na pancitopenia. Observa-se, no grupo autólogo, correlação positiva (0,76) e significativa (p < 0,04) entre o domínio cognitivo e a qualidade de vida no pós-transplante dois anos. No grupo alogênico, houve correlação positiva (0,55) e significativa (p < 0,00) a partir do pós-transplante 180 dias.
Conclusões: a qualidade de vida e a função cognitiva apresentam comprometimento e há correlação após o transplante de células-tronco hematopoéticas para ambos os grupos, autólogo e alogênico.
Downloads
Referências
Machado CAM, Proença SF, Marques ACB, Mantovani MF, Guimarães PRB, Kalinke LP. Calidad de vida de los pacientes sometidos al trasplante de células madre autólogo y alogénico en la hospitalización. Enferm. glob. [internet]. 2018;17(52):401-45. Disponible en: https://scielo.isciii.es/scielo.php?script=sci_abstract&pid=S1695-61412018000400401
Karschnia P, Parsons MW, Dietrich J. Pharmacologic management of cognitive impairment induced by cancer therapy. Lancet Oncol.. 2019;20(2):e92-102. DOI: https://doi.org/10.1016/S1470-2045(18)30938-0
Votruba KL, Hoodin F, Giordani B, Kentor R, Couriel DR, Kitko CL. Prospective computerized monitoring of cognitive functioning before and after blood and marrow transplantation. Bone marrow transplant. 2017;52(8):1215-7. DOI: https://doi.org/10.1038/bmt.2017.105
Hardy SJ, Krull KR, Wefel JS, Janelsins M. Cognitive changes in cancer survivors. Am Soc Clin Oncol Educ. 2018;23(38):795-806. Available from: https://ascopubs.org/doi/full/10.1200/EDBK_201179
Mayo S, Messner HA, Rourke SB, Howell D, Victor JC, Kuruvilla J, Lipton JH et al. Relationship between neurocognitive functioning and medication management ability over the first 6 months following allogeneic stem cell transplantation. Bone marrow transplant. 2016;51(6):841-7. DOI: https://doi.org/10.1038/bmt.2016.2
Carroll JE, Van Dyk K, Bower JE, Scuric Z, Petersen L, Schiestl R et al. Cognitive performance in survivors of breast cancer and markers of biological aging. Cancer. 2019;125(2):298-306. DOI: https://doi.org/10.1002/cncr.31777
Scuric Z, Carroll JE, Bower JE, Ramos-Perlberg S, Petersen L, Esquivel S et al. Biomarkers of aging associated with past treatments in breast cancer survivors. npj Breast Cancer. 2017;3(1). DOI: https://doi.org/10.1038/s41523-017-0050-6
Amidi A, Hosseini SMH, Leemans A, Kesler SR, Agerbaek M, Wu LM et al. Changes in brain structural networks and cognitive functions in testicular cancer patients receiving cisplatin-based chemotherapy. J natl cancer inst. 2017;109(12). DOI: https://doi.org/10.1093/jnci/djx085
Di Iulio F, Cravello L, Shofany J, Paolucci S, Caltagirone C, Morone G. Neuropsychological disorders in non-central nervous system cancer: A review of objective cognitive impairment, depression, and related rehabilitation options. Neurol. sci. 2019;40(9):1759-74. DOI: https://doi.org/10.1007/s10072-019-03898-0
Malta M, Cardoso LO, Bastos FI, Magnanini MMF, Silva CMFP. STROBE initiative: Guidelines on reporting observational studies. Rev. saúde pública. [internet]. 2010;44(3):559-65. DOI: https://doi.org/10.1590/S0034-89102010000300021
Styczyński J, Tridello G, Koster L, Iacobelli S, van Biezen A, van der Werf S et al. Death after hematopoetic stem cell transplantation: Changes over calendar year time, infections and associated factors. Bone marrow transplant. 2020;55(1):126-36. DOI: https://doi.org/10.1038/s41409-019-0624-z
Franceschini J, Jardim JR, Fernandes ALG, Jamnik S, Santoro IL. Reproducibility of the Brazilian Portuguese version of the European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire used in conjunction with its lung cancer-specific module. J. bras. pneumol. [internet]. 2010;36(5):595-602. DOI: https://doi.org/10.1590/S1806-37132010000500011
Paiva CE, Carneseca EC, Barroso EM, Camargo MG, Alfano ACC, Rugno FC et al. Further evaluation of the EORTC QLQ-C30 psychometric properties in a large Brazilian cancer patient cohort as a function of their educational status. Support. care cancer. [internet]. 2014;22(8):2151-60. DOI: https://doi.org/10.1007/s00520-014-2206-3
Fayers PM, Aaronson NK, Bjordal K, Groenvold M, Curan D, Bottoomley A. Onbehalf of the EORTC Qualityof Life Group: The EORTC QLQ C30 Scoring Manual. 3rd ed. Brussels: European Organization for Research and Treatment of Cancer; 2001. Available from: https://www.eortc.org/app/uploads/sites/2/2018/02/SCmanual.pdf
Stroup WW. Generalized linear mixed models: Modern concepts, methods and applications. Boca Raton (Florida): CRC Press; 2012.
Carreras J. A total of million stem cell transplants have been worldwide; 2017. Available from: http://www.fcarreras.org/en/a-total-of-1-million-stem-cell-transplants-have-been-performed-worldwide_147898
Associação Brasileira de Transplante de Órgãos. Registro Brasileiro de Transplantes. Dimensionamento dos transplantes no Brasil e em cada estado (2013-2020). 2020; ano XXVI(4). Disponível em: https://site.abto.org.br/wp-content/uploads/2021/03/2020-ANUAL-naoassociados-1-1.pdf
Lima CVC, Povoa RMF. Mulheres submetidas à quimioterapia e suas funções cognitivas. Psicol. ciênc. prof. 2017;37(4):970-80. DOI: https://doi.org/10.1590/1982-3703004772016
Di Giuseppe G, Thacker N, Schechter T, Pole JD. Anxiety, depression, and mental health-related quality of life in survivors of pediatric allogeneic hematopoetic stem cell transplantation: A systematic review. Bone marrow transplant. 2020;55(7):1240-54. DOI: https://doi.org/10.1038/s41409-020-0782-z
Buchbinder D, Kelly DL, Duarte RF, Savani B, Shaw BE et al. Neurocognitive dysfunction in hematopoetic cell transplant recipients: Expert review from the late effects and Quality of Life Working Committee of the CIBMTR and complications and Quality of Life Working Party of the EBMT. Bone marrow transplant. 2018;53(5):535-55. DOI: https://doi.org/10.1038/s41409-017-0055-7
Dyk KV, Bower JE, Crespi CM, Petersen L, Ganz P. Cognitive function following breast cancer treatment and associations with concurrent symptoms. Npj breast cancer. 2018;4. DOI: https://doi.org/10.1038/s41523-018-0076-4
Li TY, Chen VC, Yeh DC, Huang SL, Chen CN, Chai JW, Chen CC, Weng JC. Investigation of chemotherapy-induced brain structural alterations in breast cancer patients with generalized q-sampling MRI and graph theoretical analysis. BMC cancer. 2018;18(1):1211. DOI: https://doi.org/10.1186/s12885-018-5113-z
Andreotti C, Root JC, Ahles TA, McEwen BS, Compas BE. Cancer, coping, and cognition: A model for the role of stress reactivity in cancer-related cognitive decline. Psycho-oncol. 2015;24(6):617-23. DOI: https://doi.org/10.1002/pon.3683
Kelly DL, Buchbinder D, Duarte RF, Auletta JJ, Bhatt N, Byrne M et al. Neurocognitive dysfunction in hematopoietic cell transplant recipients: Expert review from the late effects and quality of life working Committee of the Center for International Blood and Marrow Transplant Research and complications and quality of life working party of the European Society for Blood and Marrow Transplantation. Biol. blood marrow transplant. 2018;24(2):228-41. DOI: https://doi.org/10.1016/j.bbmt.2017.09.004
Downloads
Publicado
Como Citar
Edição
Seção
Licença
Copyright (c) 2021 Aquichan
Este trabalho está licenciado sob uma licença Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
1. Proposta de Política para Periódicos de Acesso Livre
Autores que publicam nesta revista concordam com os seguintes termos:
- Esta revista e os seus artigos estão publicados com a licença Creative Commons Atribuição-NãoComercial-SemDerivações 4.0 Internacional (CC BY-NC-ND 4.0). Você tem o direito de compartilhar, copiar e redistribuir o material em qualquer suporte ou formato. Para que isto ocorra: você deve dar o crédito apropriado, prover um link para a licença e indicar se mudanças foram feitas; você não pode usar o material para fins comerciais; e, se você remixar, transformar ou criar a partir do material, você não pode distribuir o material modificado.
